Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Immune escape is a critical mechanism in cancer progression.
• The NKG2D receptor on immune cells recognizes MICA/B ligands on target cells, initiating an immune response.
• Dysregulation of immune signaling pathways contributes to tumor survival.

Purpose of the Study:

• To investigate a novel microRNA (miR)-based pathway in human lung cancer cells that facilitates immune evasion.
• To elucidate the role of miR-183 in regulating MICA/B expression and its impact on immune cell recognition.
• To identify the upstream regulators of miR-183 in lung tumor cells.

Main Methods:

• Analysis of The Cancer Genome Atlas (TCGA) database for miR-183 and MICA/B expression in lung cancer.
• In vitro studies using human lung tumor cell lines to assess the relationship between miR-183 and MICA/B.
• Luciferase reporter assays to confirm the binding site and regulatory function of miR-183 on MICA/B 3'UTR.
• Transfection experiments with antisense miR-183 and antisense TGF-beta to modulate gene expression and immune cell lysis.

Main Results:

• Human lung adenocarcinoma and squamous cell carcinoma exhibit low MICA/B and high miR-183 expression.
• miR-183 directly targets the 3' untranslated region (UTR) of MICA and MICB, leading to their repression.
• Transforming growth factor-beta (TGFβ) upregulates miR-183 expression in lung tumor cells.
• Inhibition of miR-183 restores MICA/B expression and increases tumor cell sensitivity to CD8+ T cell-mediated lysis.

Conclusions:

• A TGFβ-induced miR-183 pathway enables lung cancer cells to downregulate MICA/B, thereby evading NKG2D-mediated immune surveillance.
• Targeting this miR-183/MICA/B axis presents a potential therapeutic strategy to enhance anti-tumor immunity in lung cancer.